In this study, we found that SMAD4 is correlated with tumor differentiation, lymph node metastasis and the TNM stage of NSCLC patients but is not correlated with age or sex. This evidence concerns the gene SMAD4 and metastatic malignant neoplasm in the lymph nodes.